Business Wire

Rigaku Joins Two Partners in Establishing RIGAKU/JEOL-iCeMS Innovation Core and Concluding a Cooperation Agreement

Share

On September 4, 2025, Rigaku Corporation, a global solution partner in X-ray analytical systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President & CEO: Jun Kawakami; hereinafter “Rigaku”); Kyoto University (Main campus: Kyoto; Nagahiro Minato, President; hereinafter “Kyoto University”); and JEOL Ltd. (headquarters: Akishima, Tokyo; President & CEO: Izumi Oi, hereinafter “JEOL”) concluded an agreement to establish an organization for open innovation. The purpose of this initiative is to leverage each other’s strengths, conduct joint research and development and cultivate skilled personnel.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904601877/en/

RIGAKU/JEOL-iCeMS Innovation Core

The newly established RIGAKU/JEOL-iCeMS Innovation Core is a joint research facility founded within the Analysis Center of the Institute for Integrated Cell-Material Sciences (Kyoto University iCeMS).

RIGAKU/JEOL-iCeMS Innovation Core will apply innovative methods of molecular-structure analysis, centering on electron-beam diffraction of nanocrystals. In particular, the joint research facility will furnish a measurement environment to accelerate the search for functions in new materials, using tools such as XtaLAB Synergy-ED. (XtaLAB Synergy-ED is a radically new electron diffraction and integration platform that integrates Rigaku’s monocrystal X-ray structural-analysis technology with JEOL’s transmission electron microscopy technology.)

In this way RIGAKU/JEOL-iCeMS Innovation Core aims to advance basic research, return research results to society and cultivate skilled personnel, thereby contributing to innovation through academic-industrial partnership.

RIGAKU/JEOL-iCeMS Innovation Core is an R&D facility dedicated to the advancement of material science through open innovation. Focusing on nanocrystal materials discovered through partnership between academia and industry, RIGAKU/JEOL-iCeMS Innovation Core aims to build a platform to elucidate the relationships between structure and function of these materials and develop applications for them.

Overview of the agreement and joint research facility

Agreement period: From September 4, 2025 to March 31, 2028

Contract renewal possible

Overview of joint research facility: RIGAKU/JEOL-iCeMS Innovation Core

Joint research facility founded within iCeMS Analysis Center, Kyoto University

Comments
Jun Kawakami
President & CEO, Rigaku
I am delighted that Rigaku was able to join Kyoto University and JEOL in establishing this new research and development base. Since its foundation, Rigaku has proudly contributed to scientific progress through advancements in structural-analytical technology. Through the use of electron diffraction of nanocrystals, RIGAKU/JEOL-iCeMS Innovation Core will accelerate the development of this technology and research in its applications. We look forward to returning the knowledge obtained through this academic-industrial partnership to the broader society and using it to develop the next generation of skilled personnel on whom the future depends.

Nagahiro Minato
President, Kyoto University
With the foundation of RIGAKU/JEOL-iCeMS Innovation Core, these three partners—Rigaku, JEOL and Kyoto University—have joined hands to advance leading-edge research and development through open innovation. This initiative is one of great importance, as it dovetails with the University’s orientation to ally with analytical-device manufacturers on the concept of a core facility for Kyoto University under the plan for the University for International Research Excellence. We have high expectations that this effort will lead to strengthened research, innovation and development of outstanding personnel. Moreover, the results of this project will underpin the scientific, technological and industrial foundations not only of the three partners but of Japan in general, and will support breakthroughs in finding solutions to issues confronting society. Kyoto University will expend every effort to ensure the success of RIGAKU/JEOL-iCeMS Innovation Core.

Izumi Oi
President & CEO, JEOL
The establishment of RIGAKU/JEOL-iCeMS Innovation Core in partnership with Kyoto University and Rigaku is a vital initiative toward equipping society with revolutionary structural-analytical technologies. By developing electron diffractometers applying transmission electron microscopy technology, JEOL looks forward to advancing the structural analysis of nanocrystals and accelerating the elucidation of functions of new materials. Through the technological innovations advanced through these efforts and the products and technologies they generate, RIGAKU/JEOL-iCeMS Innovation Core will support applied research in a wide range of fields, including life sciences, the environment, energy and more, contributing to scientific progress and social development.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250904601877/en/

Contacts

Press Contact:
Sawa Himeno
Head of Communications Dept., Rigaku Holdings Corporation
prad@rigaku.co.jp
Tel: +81 90 6331 9843

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Marathon Asset Management Provides Junior Capital Financing to EXALTA Group15.12.2025 15:00:00 CET | Press Release

Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation of EXALTA through the strategic merger of three Montagu-owned companies including Intech, Resolve Surgical Technologies, and Tyber Medical. The transaction marks one of many successful transactions for Marathon’s European Credit business in the healthcare sector, where the firm has a knowledge-based advantage with a dedicated Healthcare Finance business and specialized medical advisory board providing sector insight to middle market companies. EXALTA is a global leader in orthopaedic contract design and manufacturing for spine, trauma, extremities, sports medicine and enabling technology providing comprehensive solutions to OEMs within the medical technology industry

Aurobay Technologies Expands Digital Transformation Partnership With HCLTech to Boost Manufacturing Excellence and Innovation15.12.2025 14:29:00 CET | Press Release

HCLTech, a leading global technology company, and Aurobay Technologies, a division of Horse Powertrain and a global leader in hybrid and low-emission powertrain solutions, have expanded their digital transformation partnership to support Aurobay’s global growth strategy. The expanded partnership establishes HCLTech as Aurobay Technologies’ trusted partner for managing and optimizing SAP, Siemens Teamcenter PLM software and integration services in Sweden and China. This will unlock cost efficiency, operational resilience and digital innovation across Aurobay’s manufacturing and engineering functions by leveraging HCLTech’s flagship service transformation platform, AI Force. The engagement spans core business functions including SAP operations, engineering systems, integration services and mainframe environments, reinforcing Aurobay’s focus on scale, efficiency and seamless operations across global locations. “Horse Powertrain’s division Aurobay Technologies’ digital transformation conti

Applications Now Open for the 5th Cycle of the Mohammed bin Rashid Al Maktoum Global Water Award15.12.2025 14:28:00 CET | Press Release

HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE), announced the opening of applications for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award, offering USD 1 million in prizes. The award seeks to inspire innovative, clean energy–powered solutions for water production, distribution, storage, desalination and purification, supporting global sustainability efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215897854/en/ HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE) - (Photo: AETOSWire) “Since its establishment, Suqia UAE, launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has provided clean water to nearly 15 million people in 37 countries worldwide through sustainable development and humanitarian projects.

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release

Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au

Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release

Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye